Vitamin E δ-Tocotrienol

DRUG3 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute

Conditions

Pancreatic CancerPancreatic Neoplasms

Phase 1

Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

CompletedNCT00985777

H. Lee Moffitt Cancer Center and Research InstitutePancreatic Neoplasms

Start: 2009-09-30End: 2016-02-29Updated: 2016-03-01

Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects

CompletedNCT01446952

H. Lee Moffitt Cancer Center and Research InstitutePancreatic Cancer

Start: 2011-09-30End: 2016-04-30Updated: 2016-04-11

Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects

CompletedNCT01450046

H. Lee Moffitt Cancer Center and Research InstitutePancreatic Cancer

Start: 2011-10-31End: 2016-04-30Updated: 2016-07-07

Related Papers

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia.

2015-11-1459 citations